Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: A prospective, phase III multicenter study

Journal of Urology

Volumn 174, Issue 3, 2005, Pages 862-866

  Jocham, Dieter ^a,l   Witjes, Fred ^h   Wagner, Sigrid ^b   Zeylemaker, Bram ⁱ   Van Moorselaar, Jeroen ^j   Grimm, Marc Oliver ^c   Muschter, Rolf ^d   Popken, Gralf ^e   König, Frank ^f   Knüchel, Ruth ^g   Kurth, Karl Heinz ^k  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d Helios Clinic ^*

^e HELIOS Clinic   (Germany)

^f Orthopaedic Clinic Hygiea   (Germany)

^g UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^h RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ Ziekenhuis Hilversum   (Netherlands)

^j UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l UNIVERSITY OF LÜBECK   (Germany)

more..

Author keywords

Bladder; Bladder neoplasms; Cystoscopy; Diagnostic imaging; Fluorescence

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL TRIAL; CYSTOSCOPY; DYSPLASIA; FEMALE; FLUORESCENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAPILLOMA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 23744483075     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000169257.19841.2a     Document Type: Article

References (18)

1. National Cancer Institute of the National Institutes of Health. PDQ screening and prevention for patients: screening for bladder cancer, 1999. Available at http://cancernet.nci.nih.gov/clinpdq/soa/Bladder_cancer_P.html
2. Ries, L. A. G., Miller, B. A., Hankey, B. F., Kosary, C. L., Harras, A. and Edwards, B. K.: SEER Cancer Statistics Review 1973-1991: Tables and Graphs. Washington, D. C.: National Cancer Institute, National Institutes of Health Publication No. 94-2789, 1994
3. Brausi, M., Collette, L., Kurth, K., van der Meijden, A. P., Oosterlinck, W., Witjes, J. A. et al: Variability in the recurrence rate at first follow-up cystoscopy after TUK in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol, 41: 523, 2002
4. Witjes, J. A., Kiemeney, L. A. L. M., Verbeek, A. L. M., Heijbroek, R. P. and Debruyne, F. M. J.: Random bladder biopsies and the risk of recurrence in superficial bladder cancer. A prospective study in 1026 patients. World J Urol, 10: 231, 1992
5. van der Meijden, A., Oosterlinck, W., Brausi, M., Kurth, K. H., Sylvester, R. and de Balincourt, C.: Significance of bladder biopsies in Ta, T1 bladder tumors: a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol, 35: 267, 1999
6. Zieger, K., Wolf, H., Olsen, P. R. and Hojgaard, K.: Long-term follow-up of non-invasive bladder tumours (stage Ta) recurrence and progression. Br J Urol Int, 85: 824, 2000
7. Jichlinski, P., Guillou, L., Karlsen, S. J., Malmström, P.-U., Jocham, D., Brennhovd, B. et al: Hexyl aminolevulinate fluorescence cystoscopy: a new diagnostic tool for photodiagnosis of superficial bladder cancer-a multicenter study. J Urol, 170: 226, 2003
8. Koenig, F., McGovern, F. J., Larne, R., Enquist, H., Schomacker, K. T. and Deutsch, T. F.: Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid. BJU Int, 83: 129, 1999
9. Schmidbauer, J., Witjes, F., Schmeller, N., Donat, R., Susani, M. and Marberger, M.: Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy. J Urol, 171: 135, 2004
10. Lange, N., Jichlinski, P., Zellweger, M., Forrer, M., Marti, A., Guillou, L. et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin K: a pilot study. Br J Cancer, 80:185, 1999
11. Marti, A., Lange, N., van den Bergh, H., Sedmera, D., Jichlinski, P. and Kucera, P.: Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol, 162: 546, 1999
12. Jichlinski, P., Forrer, M., Mizeret, J., Glanzmann, T., Braichotte, D., Wagnieres, G. et al: Clinical evaluation of a method for detecting superficial surgical transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin K following topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med, 20: 402, 1997
13. Kriegmair, M., Baumgartner, R., Knuchel, R., Stepp, H., Hofstädter, F. and Hofstetter, A.: Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. J Urol, 155: 105, 1996
14. Zaak, D., Kriegmair, M., Stepp, H., Stepp, H., Baumgartner, R., Oberneder, R. et al: Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies. Urology, 57: 690, 2001
15. Sobin, L. H. and Wittekind, C. H.: TNM Classification, of Malignant Tumours, 6th ed. New York: Wiley-Liss, 2002
16. Epstein, J. I., Amin, M. B., Reuter, M. D. and Mostofi, F. K.: Th World Health Organisation/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol, 22: 1435, 1998
17. Mostofi, F. K., Sobin, L. H. and Torloni, H.: Histopathological typing of urinary bladder tumours. In: World Health Organization International Histological Classification of Tumours. Geneva, Switzerland: World Health Organization, 1973
18. Klän R, Loy, V. and Huland, H.: Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder. J Urol, 146: 316, 1991